Drugmaker AstraZeneca forecasts faster return to growth YoopyaJan 14, 2014November 29, 20230 (Reuters) – AstraZeneca expects new drugs to offset a looming wave of patent expiries and return it to growth faster than analysts predict, with 2017 Read more